Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 282 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
MERCK & CO, INC. for MERCK & CO INC
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals
View →
Q2
EMD SERONO, INC. for EMD SERONO INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
PFIZER INC. for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q2
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Agriculture
View →
Q2
THE MCMANUS GROUP for GENENTECH
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q2
THE MCMANUS GROUP for EMD SERONO, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
THE MCMANUS GROUP for GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
THE MCMANUS GROUP for AMGEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Agriculture, Animals, Budget/Appropriations
View →
Q2
TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Trade (domestic/foreign)
View →
Q2
W STRATEGIES, LLC for SANOFI U.S. SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q2
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q2
INTRA-CELLULAR THERAPIES, INC. for INTRA-CELLULAR THERAPIES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate
Medicare/Medicaid
View →
Q2
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
2A
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Taxation/Internal Revenue Code, Banking, Budget/Appropriations, Civil Rights/Civil Liberties
View →
Q2
DLA PIPER LLP (US) for BIOGEN, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products
View →
Previous Page 8 of 12 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem